Integral Health Asset Management, LLC
Filing Date
Global Rank
#1,173
/ 8,623
▲ 56
· as of Mar 2026
Top Industry
Biotechnology
69.7%
3Y Alpha vs SPY
-0.5%
Period ended 4 months ago
Filed May 15, 2026 · 3mo
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Cloned portfolio
+64.2%
SPY
+65.3%
Annualised alpha
-0.3%
Max drawdown
−26.3%
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 96% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
86 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
12.8%
+1.8 pts
Top 5
38.9%
+8.3 pts
Top 10
51.8%
+7.9 pts
HHI
470
Diversified+151
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $2,090,923,180 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| RVMD | Revolution Medicines, Inc. | +1,550,000 | 2,750,000 | $267,437,500 | |
| LFST | LifeStance Health Group, Inc. | +1,300,000 | 4,300,000 | $27,391,000 | |
| ROIV | Roivant Sciences Ltd. | +1,150,000 | 2,000,000 | $55,400,000 | |
| CYTK | Cytokinetics Inc | +700,000 | 2,600,000 | $171,366,000 | |
| BTSG | BrightSpring Health Services, Inc. | +500,000 | 1,250,000 | $53,262,500 | |
| NRIX | Nurix Therapeutics, Inc. | +400,000 | 700,000 | $10,850,000 | |
| ALHC | Alignment Healthcare, Inc. | +375,000 | 2,575,000 | $45,371,500 | |
| BSX | Boston Scientific Corp | +325,000 | 550,000 | $34,512,500 | |
| ELAN | Elanco Animal Health Inc | +300,000 | 550,000 | $13,161,500 | |
| RGNX | REGENXBIO Inc. | +300,000 | 1,500,000 | $12,570,000 | |
| MLYS | Mineralys Therapeutics, Inc. | +250,000 | 1,250,000 | $33,862,500 | |
| TNGX | Tango Therapeutics, Inc. | +250,000 | 450,000 | $9,414,000 | |
| INSM | INSMED Inc | +250,000 | 1,500,000 | $245,280,000 | |
| SANA | Sana Biotechnology, Inc. | +200,000 | 3,200,000 | $9,216,000 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | +200,000 | 300,000 | $18,810,000 | |
| ORIC | Oric Pharmaceuticals, Inc. | +200,000 | 1,400,000 | $17,738,000 | |
| SRRK | Scholar Rock Holding Corp | +200,000 | 500,000 | $24,580,000 | |
| MRK | Merck & Co., Inc. | +175,000 | 425,000 | $51,123,250 | |
| VKTX | Viking Therapeutics, Inc. | +150,000 | 250,000 | $8,135,000 | |
| SNDX | Syndax Pharmaceuticals Inc | +150,000 | 350,000 | $8,176,000 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | +125,000 | 600,000 | $52,182,000 | |
| ANRO | Alto Neuroscience, Inc. | +125,000 | 500,000 | $11,240,000 | |
| FMS | Fresenius Medical Care AG | +125,000 | 775,000 | $17,484,000 | |
| EWTX | Edgewise Therapeutics, Inc. | +100,000 | 1,600,000 | $50,400,000 | |
| EVMN | Evommune, Inc. | +100,000 | 225,000 | $5,172,750 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
17 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| TARA | Protara Therapeutics, Inc. | −500,000 | 1,750,000 | $9,117,500 | |
| BHVN | Biohaven Ltd. | −500,000 | 1,000,000 | $8,460,000 | |
| IKT | Inhibikase Therapeutics, Inc. | −400,000 | 1,350,000 | $2,268,000 | |
| CVS | CVS HEALTH Corp | −350,000 | 150,000 | $10,773,000 | |
| DXCM | Dexcom Inc | −325,000 | 175,000 | $10,990,000 | |
| BEAM | Beam Therapeutics Inc. | −250,000 | 300,000 | $7,149,000 | |
| VERA | Vera Therapeutics, Inc. | −200,000 | 1,600,000 | $64,368,000 | |
| COO | Cooper Companies, Inc. | −175,000 | 150,000 | $10,725,000 | |
| EW | Edwards Lifesciences Corp | −155,000 | 170,000 | $13,613,600 | |
| GKOS | GLAUKOS Corp | −150,000 | 175,000 | $18,840,500 | |
| NVST | Envista Holdings Corp | −150,000 | 350,000 | $8,879,500 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | −125,000 | 150,000 | $12,588,000 | |
| ISRG | Intuitive Surgical Inc | −75,000 | 35,000 | $16,134,650 | |
| BIIB | Biogen Inc. | −40,000 | 60,000 | $10,999,800 | |
| REGN | Regeneron Pharmaceuticals, Inc. | −20,000 | 85,000 | $65,674,400 | |
| DGX | Quest Diagnostics Inc | −15,000 | 60,000 | $11,758,800 | |
| LLY | ELI LILLY & Co | −5,000 | 15,000 | $13,796,550 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AZN | Astrazeneca PLC | 250,000 | $49,305,000 | |
| BBIO | BridgeBio Pharma, Inc. | 275,000 | $20,421,500 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | 40,000 | $17,861,600 | |
| ALMS | Alumis Inc. | 800,000 | $17,624,000 | |
| GILD | Gilead Sciences, Inc. | 100,000 | $13,937,000 | |
| COGT | Cogent Biosciences, Inc. | 350,000 | $13,471,500 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | 25,000 | $13,086,750 | |
| XENE | Xenon Pharmaceuticals Inc. | 200,000 | $11,630,000 | |
| ERAS | Erasca, Inc. | 700,000 | $11,326,000 | |
| IRON | Disc Medicine, Inc. | 170,000 | $10,869,800 | |
| TMO | Thermo Fisher Scientific Inc. | 20,000 | $9,830,600 | |
| LIVN | LivaNova PLC | 150,000 | $9,534,000 | |
| IONS | Ionis Pharmaceuticals Inc | 125,000 | $9,386,250 | |
| DFTX | Definium Therapeutics, Inc. | 400,000 | $7,560,000 | |
| CAPR | Capricor Therapeutics, Inc. | 200,000 | $6,080,000 | |
| IQV | Iqvia Holdings Inc. | 35,000 | $5,968,900 | |
| AXSM | Axsome Therapeutics, Inc. | 35,000 | $5,915,700 | |
| PTGX | Protagonist Therapeutics, Inc | 50,000 | $5,270,000 | |
| ACHC | Acadia Healthcare Company, Inc. | 200,000 | $4,678,000 | |
| ZBH | Zimmer Biomet Holdings, Inc. | 50,000 | $4,521,000 | |
| FBRX | Forte Biosciences, Inc. | 150,000 | $3,885,000 | |
| SVRA | Savara Inc | 600,000 | $3,276,000 | |
| RLMD | Relmada Therapeutics, Inc. | 450,000 | $3,132,000 | |
| IMCR | Immunocore Holdings plc | 100,000 | $3,015,000 | |
| OLMA | Olema Pharmaceuticals, Inc. | 150,000 | $2,236,500 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
24 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MDT | Medtronic plc | 675,000 | $64,840,500 | |
| TEVA | Teva Pharmaceutical Industries Ltd | 1,000,000 | $31,210,000 | |
| PEN | Penumbra Inc | 100,000 | $31,091,000 | |
| TFX | Teleflex Inc | 250,000 | $30,510,000 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 60,000 | $23,859,000 | |
| IRTC | iRhythm Holdings, Inc. | 130,000 | $23,067,200 | |
| UPB | Upstream Bio, Inc. | 750,000 | $20,362,500 | |
| THC | Tenet Healthcare Corp | 100,000 | $19,872,000 | |
| DOCS | Doximity, Inc. | 400,000 | $17,712,000 | |
| TERN | Terns Pharmaceuticals, Inc. | 425,000 | $17,170,000 | |
| UNH | Unitedhealth Group Inc | 50,000 | $16,505,500 | |
| RDNT | RadNet, Inc. | 200,000 | $14,270,000 | |
| ACLX | Arcellx, Inc. | 200,000 | $13,040,000 | |
| EHC | Encompass Health Corp | 100,000 | $10,614,000 | |
| CRL | Charles River Laboratories International, Inc. | 45,000 | $8,976,600 | |
| INSP | Inspire Medical Systems, Inc. | 75,000 | $6,917,250 | |
| BRKR | Bruker Corp | 125,000 | $5,888,750 | |
| APLS | Apellis Pharmaceuticals, Inc. | 200,000 | $5,024,000 | |
| EYPT | EyePoint, Inc. | 200,000 | $3,654,000 | |
| GPCR | Structure Therapeutics Inc. | 50,000 | $3,477,500 | |
| SGHT | Sight Sciences, Inc. | 425,000 | $3,370,250 | |
| GOSS | Gossamer Bio, Inc. | 1,000,000 | $3,100,000 | |
| OSCR | Oscar Health, Inc. | 200,000 | $2,874,000 | |
| BCRX | Biocryst Pharmaceuticals Inc | 200,000 | $1,560,000 | |
| No positions match the current search. | ||||
86 tracked positions ·
$2,090,923,180 total
· filing declares
90 positions · $2,090,923,180
· as of Mar 31, 2026
Showing 1–50
of 86 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
PUT
CALL
+ SHARES
Healthcare
|
Added | 2,750,000 | $267,437,500 | 12.79% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 1,500,000 | $245,280,000 | 11.73% | |
| CYTK |
Cytokinetics Inc
CALL
+ SHARES
Healthcare
|
Added | 2,600,000 | $171,366,000 | 8.20% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Reduced | 85,000 | $65,674,400 | 3.14% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 1,600,000 | $64,368,000 | 3.08% | |
| CAH |
Cardinal Health Inc
Healthcare
|
Added | 270,000 | $57,053,700 | 2.73% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Added | 2,000,000 | $55,400,000 | 2.65% | |
| BTSG |
BrightSpring Health Services, Inc.
Healthcare
|
Added | 1,250,000 | $53,262,500 | 2.55% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Added | 600,000 | $52,182,000 | 2.50% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Added | 425,000 | $51,123,250 | 2.45% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Added | 1,600,000 | $50,400,000 | 2.41% | |
| AZN |
Astrazeneca PLC
Healthcare
|
NEW | 250,000 | $49,305,000 | 2.36% | |
| ALHC |
Alignment Healthcare, Inc.
Healthcare
|
Added | 2,575,000 | $45,371,500 | 2.17% | |
| NVS |
Novartis AG
Healthcare
|
Held | 250,000 | $38,187,500 | 1.83% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 550,000 | $34,512,500 | 1.65% | |
| MLYS |
Mineralys Therapeutics, Inc.
CALL
+ SHARES
Healthcare
|
Added | 1,250,000 | $33,862,500 | 1.62% | |
| LFST |
LifeStance Health Group, Inc.
Healthcare
|
Added | 4,300,000 | $27,391,000 | 1.31% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Added | 115,000 | $26,303,950 | 1.26% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Added | 500,000 | $24,580,000 | 1.18% | |
| ELV |
Elevance Health, Inc.
Healthcare
|
Added | 75,000 | $21,956,250 | 1.05% | |
| CNC |
Centene Corp
Healthcare
|
Held | 650,000 | $21,281,000 | 1.02% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
NEW | 275,000 | $20,421,500 | 0.98% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Held | 150,000 | $19,761,000 | 0.95% | |
| GKOS |
GLAUKOS Corp
Healthcare
|
Reduced | 175,000 | $18,840,500 | 0.90% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Added | 300,000 | $18,810,000 | 0.90% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
NEW | 40,000 | $17,861,600 | 0.85% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Added | 1,400,000 | $17,738,000 | 0.85% | |
| ALMS |
Alumis Inc.
Healthcare
|
NEW | 800,000 | $17,624,000 | 0.84% | |
| FMS |
Fresenius Medical Care AG
Healthcare
|
Added | 775,000 | $17,484,000 | 0.84% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Reduced | 35,000 | $16,134,650 | 0.77% | |
| QURE |
uniQure N.V.
Healthcare
|
Held | 900,000 | $14,715,000 | 0.70% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Held | 200,000 | $14,030,000 | 0.67% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
NEW | 100,000 | $13,937,000 | 0.67% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 15,000 | $13,796,550 | 0.66% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Reduced | 170,000 | $13,613,600 | 0.65% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
NEW | 350,000 | $13,471,500 | 0.64% | |
| ELAN |
Elanco Animal Health Inc
Healthcare
|
Added | 550,000 | $13,161,500 | 0.63% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
NEW | 25,000 | $13,086,750 | 0.63% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Held | 40,000 | $12,887,600 | 0.62% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Reduced | 150,000 | $12,588,000 | 0.60% | |
| RGNX |
REGENXBIO Inc.
Healthcare
|
Added | 1,500,000 | $12,570,000 | 0.60% | |
| DGX |
Quest Diagnostics Inc
Healthcare
|
Reduced | 60,000 | $11,758,800 | 0.56% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
NEW | 200,000 | $11,630,000 | 0.56% | |
| ERAS |
Erasca, Inc.
Healthcare
|
NEW | 700,000 | $11,326,000 | 0.54% | |
| ANRO |
Alto Neuroscience, Inc.
Healthcare
|
Added | 500,000 | $11,240,000 | 0.54% | |
| BIIB |
Biogen Inc.
Healthcare
|
Reduced | 60,000 | $10,999,800 | 0.53% | |
| DXCM |
Dexcom Inc
Healthcare
|
Reduced | 175,000 | $10,990,000 | 0.53% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Held | 325,000 | $10,881,000 | 0.52% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
NEW | 170,000 | $10,869,800 | 0.52% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Added | 700,000 | $10,850,000 | 0.52% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.